CIK: 1246842 - Address: C/o Revolution Medicines, Inc., 700 Saginaw Drive, Redwood City, CA 94063
23 results

TC

Stat

Stk

Ins

Fil

+d

+w

+m

+q

+h

+y

avg

Filing Date

T Date

Ticker

Issuer

Inc

Sector

Ind

Industry

Owner

oSt

Rel

Title

T

TVal

Price

L

Qty

oc

Own

H

r2y

r1y

r6m

r3m

r6w

r3w

r7d

r3d

f1d

f1w

f1m

f3m

f6m

f1y

10/15/24 17:30
10/11/24
RVMDRevolution Medicines, Inc.DEHealthBioPrdBiological Products, (No DiagGoldsmith Mark ACADOSee RemaM.d1234.090304817D
10/15/24 17:30
10/11/24
RVMDRevolution Medicines, Inc.DEHealthBioPrdBiological Products, (No DiagGoldsmith Mark ACADOSee RemaS.d-1,51150.360-30-4817D
10/3/24 16:33
10/1/24
RVMDRevolution Medicines, Inc.DEHealthBioPrdBiological Products, (No DiagGoldsmith Mark ACADOSee RemaM.d414.090101817D
10/3/24 16:33
10/1/24
RVMDRevolution Medicines, Inc.DEHealthBioPrdBiological Products, (No DiagGoldsmith Mark ACADOSee RemaS.d-44944.930-10-1817D
9/18/24 16:18
9/16/24
RVMDRevolution Medicines, Inc.DEHealthBioPrdBiological Products, (No DiagGoldsmith Mark ACADOSee RemaS-51844.190-12-1817D
8/2/24 17:35
8/1/24
RVMDRevolution Medicines, Inc.DEHealthBioPrdBiological Products, (No DiagGoldsmith Mark ACADOSee RemaM.d414.090101828D
8/2/24 17:35
8/1/24
RVMDRevolution Medicines, Inc.DEHealthBioPrdBiological Products, (No DiagGoldsmith Mark ACADOSee RemaS.d-45945.880-10-1828D
7/16/24 17:05
7/12/24
RVMDRevolution Medicines, Inc.DEHealthBioPrdBiological Products, (No DiagGoldsmith Mark ACADOSee RemaM.d1024.090253803M
7/16/24 17:05
7/12/24
RVMDRevolution Medicines, Inc.DEHealthBioPrdBiological Products, (No DiagGoldsmith Mark ACADOSee RemaS.d-1,57645.040-35-4803M
6/20/24 16:14
6/17/24
RVMDRevolution Medicines, Inc.DEHealthBioPrdBiological Products, (No DiagGoldsmith Mark ACADOSee RemaS-44737.390-12-1838D
6/5/24 16:18
6/3/24
RVMDRevolution Medicines, Inc.DEHealthBioPrdBiological Products, (No DiagGoldsmith Mark ACADOSee RemaM.d314.09081849D
6/5/24 16:18
6/3/24
RVMDRevolution Medicines, Inc.DEHealthBioPrdBiological Products, (No DiagGoldsmith Mark ACADOSee RemaS.d-30039.990-8-1849D
4/12/24 20:08
4/10/24
RVMDRevolution Medicines, Inc.DEHealthBioPrdBiological Products, (No DiagGoldsmith Mark ACADOSee RemaS-61935.400-18-2811M
3/20/24 16:44
3/18/24
RVMDRevolution Medicines, Inc.DEHealthBioPrdBiological Products, (No DiagGoldsmith Mark ACADOSee RemaS-18331.580-6-1859D
12/20/23 17:08
12/18/23
RVMDRevolution Medicines, Inc.DEHealthBioPrdBiological Products, (No DiagGoldsmith Mark ACADOSee RemaS-21125.900-8-1775D
10/24/23 19:21
10/24/23
RVMDRevolution Medicines, Inc.DEHealthBioPrdBiological Products, (No DiagGoldsmith Mark ACADOSee RemaM.d170.49000355783D
9/20/23 16:12
9/18/23
RVMDRevolution Medicines, Inc.DEHealthBioPrdBiological Products, (No DiagGoldsmith Mark ACADOSee RemaS-25231.310-8-1748D
9/6/23 20:05
9/1/23
RVMDRevolution Medicines, Inc.DEHealthBioPrdBiological Products, (No DiagGoldsmith Mark ACADOSee RemaM.d230.77210304720M
9/6/23 20:05
9/1/23
RVMDRevolution Medicines, Inc.DEHealthBioPrdBiological Products, (No DiagGoldsmith Mark ACADOSee RemaS.d-1,40235.050-40-5720M
2/23/23 19:33
2/22/23
RVMDRevolution Medicines, Inc.DEHealthBioPrdBiological Products, (No DiagGoldsmith Mark ACADOSee RemaM.d220.49000457660D
8/15/22 16:56
8/11/22
RVMDRevolution Medicines, Inc.DEHealthBioPrdBiological Products, (No DiagGoldsmith Mark ACADOSee RemaM.d50.49000102547D
8/10/22 17:01
8/9/22
RVMDRevolution Medicines, Inc.DEHealthBioPrdBiological Products, (No DiagGoldsmith Mark ACADOSee RemaM.d50.49000102537D
3/21/22 20:02
3/17/22
RVMDRevolution Medicines, Inc.DEHealthBioPrdBiological Products, (No DiagGoldsmith Mark ACADOSee RemaS-1918.610-10526D

DDerivative transaction in filing (usually option exercise)
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
AAmended filing
EError detected in filing
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top

Contact